相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes - Data from a randomized, placebo-controlled study
Matthias Rau et al.
BONE REPORTS (2022)
Bone Fragility Fractures in CKD Patients
Ana Pimentel et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients
Yoshitaka Isaka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
Jordi Bover et al.
CLINICAL KIDNEY JOURNAL (2021)
Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis
Katharina Doerr et al.
CIRCULATION RESEARCH (2021)
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
Bertram Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
Mario Cozzolino et al.
CLINICAL KIDNEY JOURNAL (2021)
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release Calcifediol
George Fadda et al.
AMERICAN JOURNAL OF NEPHROLOGY (2021)
How FGF23 shapes multiple organs in chronic kidney disease
Maren Leifheit-Nestler et al.
MOLECULAR AND CELLULAR PEDIATRICS (2021)
Small Intestinal Phosphate Absorption: Novel Therapeutic Implications
Jerry Yee et al.
AMERICAN JOURNAL OF NEPHROLOGY (2021)
Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease
David Galuska et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2021)
Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
Tamara Isakova et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
Andrew S. Levey et al.
KIDNEY INTERNATIONAL (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
Maria L. Mace et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prevalence and influencing factors of vitamin D deficiency in chronic kidney disease: A cross-sectional study
Minxia Li et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2020)
Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease
S. Geng et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion
Patricia P. Centeno et al.
NATURE COMMUNICATIONS (2019)
Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis
Maarten A. de Jong et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study
Umut Selamet et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update
Markus Ketteler et al.
ANNALS OF INTERNAL MEDICINE (2018)
Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies
Pedro Henrique Franca Gois et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Foreword
David C. Wheeler et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2017)
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease
Stuart M. Sprague et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2017)
High prevalence of vitamin D deficiency among children with chronic kidney disease and kidney transplant
Paula Coccia et al.
ARCHIVOS ARGENTINOS DE PEDIATRIA (2017)
Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs
Shuanhu Zhou et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Shunsuke Yamada et al.
BONE (2017)
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology
Keith A. Hruska et al.
BONE (2017)
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
Stuart M. Sprague et al.
AMERICAN JOURNAL OF NEPHROLOGY (2016)
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial
Andreas Tomaschitz et al.
JOURNAL OF HYPERTENSION (2016)
Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease
Rajiv Agarwal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Vascular Calcification in Patients with Nondialysis CKD over 3 Years
Jose L. Gorriz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Modified-release oral calcifediol corrects vitamin D insufficiency with minimal CYP24A1 upregulation
Martin Petkovich et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
Jose Luis Fernandez-Martin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Effect of Paricalcitol on Left Ventricular Mass and Function in CKD-The OPERA Trial
Angela Yee-Moon Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The three-year incidence of fracture in chronic kidney disease
Kyla L. Naylor et al.
KIDNEY INTERNATIONAL (2014)
1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism
Monika H. E. Christensen et al.
PLOS ONE (2013)
Ergocalciferol and Cholecalciferol in CKD
Sagar U. Nigwekar et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options
John Cunningham et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Paricalcitol and outcome: A manual on how a vitamin D receptor activator (VDRA) can help us to get down the “U”
M. Cozzolino et al.
CLINICAL NEPHROLOGY (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
Katherine Wesseling-Perry et al.
KIDNEY INTERNATIONAL (2011)
Vascular calcification: Inducers and inhibitors
Donghyun Lee
MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS (2011)
Mechanisms and treatment of extraosseous calcification in chronic kidney disease
Markus Ketteler et al.
NATURE REVIEWS NEPHROLOGY (2011)
Clinical Outcomes with Active versus Nutritional Vitamin D Compounds in Chronic Kidney Disease
Kamyar Kalantar-Zadeh et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Adynamic bone disease-bone and beyond
Vincent M. Brandenburg et al.
CLINICAL KIDNEY JOURNAL (2008)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies
Tilman Drueke et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Chronic kidney disease-mineral-bone disorder: A new paradigm
Sharon M. Moe et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2007)
Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities
Samina Khan
NEPHRON CLINICAL PRACTICE (2007)
Calcification and cardiovascular health - New insights into an old phenomenon
Markus Ketteler et al.
HYPERTENSION (2006)
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism
M Rodriguez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
GM Chertow et al.
AMERICAN JOURNAL OF NEPHROLOGY (2003)
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
M Teng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pathogenesis and treatment of renal osteodystrophy
E Slatopolsky et al.
BLOOD PURIFICATION (2003)
Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?
P Raggi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects
F Llach et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
